Results 1 to 10 of about 2,498 (169)

Oral Immunotherapy (OIT): A Personalized Medicine [PDF]

Medicina, 2019
Oral Immunotherapy (OIT), a promising allergen-specific approach in the management of Food Allergies (FA), is based on the administration of increasing doses of the culprit food until reaching a maintenance dose.
Francesca Mori, Simona Barni, Giulia Liccioli, Elio Novembre   +3 more
doaj   +2 more sources

Bronchial hyperresponsiveness and asthma during oral immunotherapy for egg or peanut allergy in children [PDF]

Clinical and Translational Allergy, 2022
Background Bronchial hyperresponsiveness (BHR) and asthma are frequently present in children with food allergy. We assessed BHR in children receiving oral immunotherapy (OIT) for persistent egg or peanut allergy and examined whether OIT affects asthma ...
Janne Burman, Kati Palosuo, Anna Pelkonen, Pekka Malmberg, Sami Remes, Kaarina Kukkonen, Mika J. Mäkelä   +6 more
doaj   +2 more sources

Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond [PDF]

Frontiers in Allergy, 2021
The coronavirus disease 2019 (COVID-19) pandemic has led to the deprioritization of non-emergency services, such as oral food challenges and the initiation of oral immunotherapy (OIT) for food-allergic children.
Gilbert T. Chua, Edmond S. Chan, Edmond S. Chan, Lianne Soller, Lianne Soller, Victoria E. Cook, Victoria E. Cook, Timothy K. Vander Leek, Raymond Mak   +8 more
doaj   +3 more sources

Therapeutic perspectives in food allergy [PDF]

Journal of Translational Medicine, 2020
Background In the last twenty years, several studies have been conducted in the search for new therapeutic strategies in patients with food allergy; in particular, after the failure of injection immunotherapy, three different routes of administration ...
Francesco Marcucci, Chiara Isidori, Alberto Argentiero, Cosimo Neglia, Susanna Esposito   +4 more
doaj   +3 more sources

Hazelnut oral immunotherapy in children: An Italian single-center retrospective cohort study. [PDF]

Pediatr Allergy Immunol
Abstract Introduction Hazelnut oral immunotherapy (H‐OIT) is a promising treatment for hazelnut allergy (HA). The aim of this study was to assess the safety and efficacy of H‐OIT in a pediatric population, while describing its clinical and allergy characteristics. Methods Children undergoing H‐OIT at our tertiary pediatric hospital Allergy Unit between
Barni S, Pessina B, Della Femina S, Catamerò F, Valleriani C, Giovannini M, Liccioli G, Sarti L, Tomei L, Mori F.   +9 more
europepmc   +2 more sources

Wheat allergy, a new and emerging threat of food allergy for children. [PDF]

Pediatr Allergy Immunol
Abstract Compared to cow's milk, eggs and peanut, knowledge on wheat allergy is limited. During the past 2 decades, IgE‐mediated wheat allergy in children has been frequently observed all over the World, especially in Asia. Wheat allergy usually presents in infants between 6 and 12 months of age.
Vichyanond P, Nagakura KI, Pacharn P, Wong G, Sampson HA.   +4 more
europepmc   +2 more sources

Variation in pediatric egg and milk allergy management: A multinational survey in Ireland, Spain, and Canada. [PDF]

Pediatr Allergy Immunol
Pediatric Allergy and Immunology, Volume 37, Issue 2, February 2026.
Gallagher A, Protudjer JLP, Mack DP, de Los Angeles Gonzalez Labrador M, Muñoz C, Cronin C, Trujillo J.   +6 more
europepmc   +2 more sources

Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study) [PDF]

BMJ Open, 2020
Introduction Peanut allergy is the the most common cause of life-threatening food-induced anaphylaxis. There is currently no effective long-term treatment.
, Michael O’Sullivan, Michael S Gold, Francesca Orsini, Adriana Chebar Lozinsky, Paxton Loke, Susan L. Prescott, Patrick Quinn, Audrey DunnGalvin, Mimi LK Tang, Anne-Louise Ponsoby, Ee Lyn Su, Marnie Robinson, Dean Tey, Kuang-Chih Hsiao, Molly O’Sullivan, Christine Axelrad, Sigrid Pitkin, Jessica Metcalfe, Susan Fahy-Scheer, Thalayasingam Meera, Jovanka King, Fuad Abass, Abigail Cheung, Rachel Wallace, Samara Baldwin   +25 more
doaj   +2 more sources

Life‐threatening anaphylaxis in children with cow's milk allergy during oral immunotherapy and after treatment failure [PDF]

Immunity, Inflammation and Disease, 2022
Background Oral immunotherapy (OIT) is a promising therapeutic approach for children with persistent IgE‐mediated cow's milk allergy (CMA) but data are still limited.
Laura Badina, Francesca Burlo, Beatrice Belluzzi, Sara Babich, Irene Berti, Egidio Barbi   +5 more
doaj   +2 more sources

Safety and Efficacy of Very Low-Dose Multi-Nut Oral Immunotherapy in Children. [PDF]

Clin Transl Allergy
ABSTRACT Background Oral immunotherapy (OIT) is a management strategy for food allergies, typically one at a time, with maintenance doses ≥ 300 mg protein. However, 30% of allergic children have multiple trigger foods, and large maintenance doses are associated with side effects. If efficacious, Very Low‐Dose OIT (VLOIT) may enhance safety in multi‐OIT.
Upton JEM, Li CH, Berenjy A, Galper A, Yin X, Celik A, Duan L, Wong S, Ditlof CM, San Diego KE, Hoang JA, Ben-Shoshan M, Kothari A, Hung L, Monteiro M, Phue WH, Moraes TJ, Eiwegger T.   +17 more
europepmc   +2 more sources